These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31996060)

  • 1. Livedo Racemosa: Clinical, Laboratory, and Histopathological Findings in 33 Patients.
    Pincelli MS; Echavarria AMJ; Criado PR; Marques GF; Morita TCAB; Valente NYS; de Carvalho JF
    Int J Low Extrem Wounds; 2021 Mar; 20(1):22-28. PubMed ID: 31996060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.
    Martínez-Valle F; Ordi-Ros J; Selva-O'Callaghan A; Balada E; Solans-Laque R; Vilardell-Tarres M
    Med Clin (Barc); 2009 May; 132(20):767-71. PubMed ID: 19403146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.
    Kraemer M; Linden D; Berlit P
    J Neurol; 2005 Oct; 252(10):1155-66. PubMed ID: 16133722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity.
    Assan F; Bottin L; Francès C; Moguelet P; Tavolaro S; Barbaud A; de Zuttere D; Alamowitch S; Chasset F
    Ann Dermatol Venereol; 2022 Mar; 149(1):3-13. PubMed ID: 34740467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedo racemosa, secondary to drug-induced systemic lupus erythematosus.
    Defelice T; Lu P; Loyd A; Patel R; Franks AG
    Dermatol Online J; 2010 Nov; 16(11):24. PubMed ID: 21163175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine-Induced Livedo Racemosa.
    Criado PR; Alavi A; Valente NY; Sotto MN
    Int J Low Extrem Wounds; 2016 Mar; 15(1):78-81. PubMed ID: 26338517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: Report of 22 cases and literature review.
    Criado PR; Marques GF; Morita TC; de Carvalho JF
    Autoimmun Rev; 2016 Jun; 15(6):558-63. PubMed ID: 26876385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon's syndrome.
    Ohtani H; Imai H; Yasuda T; Wakui H; Komatsuda A; Hamai K; Miura AB
    Am J Kidney Dis; 1995 Sep; 26(3):511-5. PubMed ID: 7645561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous vasculitis in autoinflammatory diseases.
    Chen KR
    J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Livedo: from pathophysiology to diagnosis].
    Duval A; Pouchot J
    Rev Med Interne; 2008 May; 29(5):380-92. PubMed ID: 18374456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Soma Y
    Medicine (Baltimore); 2011 Mar; 90(2):119-124. PubMed ID: 21358438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.
    Stockhammer G; Felber SR; Zelger B; Sepp N; Birbamer GG; Fritsch PO; Aichner FT
    Stroke; 1993 May; 24(5):685-90. PubMed ID: 8488523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of intradermal blood vessel structures by dual-wavelength photoacoustic microscopy and characterization of three-dimensional construction of livedo-racemosa in cutaneous polyarteritis nodosa.
    Sujino K; Tanese K; Saito Y; Kuramoto J; Iwazaki H; Ida T; Aiso S; Imanishi N; Kajita H; Fukuda K; Amagai M; Tanikawa A
    J Dermatol Sci; 2024 May; 114(2):71-78. PubMed ID: 38644095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panarteritis cutanea benigna--an entity limited to the skin or cutaneous presentation of a systemic necrotizing vasculitis? Report of seven cases and review of the literature.
    Rogalski C; Sticherling M
    Int J Dermatol; 2007 Aug; 46(8):817-21. PubMed ID: 17651163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedo reticularis and related disorders.
    Dean SM
    Curr Treat Options Cardiovasc Med; 2011 Apr; 13(2):179-91. PubMed ID: 21287303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedo racemosa and thrombotic vasculitides of scalp in systemic lupus erythematosus.
    Lee JY; Tsai CY; Liao HT
    Ann Rheum Dis; 2022 Oct; 81(10):1474. PubMed ID: 35788495
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of MPO-ANCA-positive cutaneous polyarteritis nodosa with livedo racemosa arising from immune-deposit-positive necrotizing vasculitis.
    Miyazawa R; Tanei R; Tsuchida M; Sugihara T
    G Ital Dermatol Venereol; 2020 Jun; 155(3):357-358. PubMed ID: 30636392
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa: Clinicopathologic comparison with blinded histologic assessment.
    Kelly RI; Wee E; Balta S; Williams RA
    J Am Acad Dermatol; 2020 Aug; 83(2):501-508. PubMed ID: 32044177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.